Results 241 to 250 of about 302,293 (261)
Some of the next articles are maybe not open access.
Oligonucleotides, 2007
The present study aims to evaluate the antigenicity of a PNA complementary to the Emu sequence (PNAEmu) with cancer therapeutic potential properties in Burkitt's lymphoma (BL). In BL cells, the c-myc oncogene is repositioned next to the Emu enhancer of the immunoglobulin (Ig) locus, due to chromosomal translocation, and up-regulated. PNAEmu linked to a
CUTRONA G. +7 more
openaire +2 more sources
The present study aims to evaluate the antigenicity of a PNA complementary to the Emu sequence (PNAEmu) with cancer therapeutic potential properties in Burkitt's lymphoma (BL). In BL cells, the c-myc oncogene is repositioned next to the Emu enhancer of the immunoglobulin (Ig) locus, due to chromosomal translocation, and up-regulated. PNAEmu linked to a
CUTRONA G. +7 more
openaire +2 more sources
Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer
BioTech, 2022Shrey Kanvinde +2 more
exaly
Nucleic Acid Tests for Clinical Translation
Chemical Reviews, 2021Min Li, Yin Fangfei, Lu Song
exaly
Self-Assembling Nucleic Acid Nanostructures Functionalized with Aptamers
Chemical Reviews, 2021Abhichart Krissanaprasit +2 more
exaly
Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Nature Reviews Drug Discovery, 2019Claire Vanpouille-Box, Lorenzo Galluzzi
exaly
Rationally Engineered Nucleic Acid Architectures for Biosensing Applications
Chemical Reviews, 2019Mingshu Xiao, Wei Lai, Binbin Chang
exaly
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Chemical Reviews, 2015Ulrich Lächelt, Ernst Wagner
exaly
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Advanced Materials, 2020Hannah J Vaughan +2 more
exaly